购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Akt
    (1)
  • VEGFR
    (1)
  • Others
    (3)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 35日内发货
    (1)
  • 6-8周
    (2)
筛选
搜索结果
TargetMol产品目录中 "

hydrogen sulfide-releasing

"的结果
  • 抑制剂&激动剂
    4
    TargetMol | Inhibitors_Agonists
  • PROTAC
    1
    TargetMol | PROTAC
  • Desmethylanethol trithione
    ADT-OH
    T356018274-81-2
    Desmethylanethol trithione (ADT-OH) 是合成硫化氢的供体。它利用上调 FADD 诱导细胞凋亡,并对体内黑色素瘤的形成具有一定的抑制作用,可用于研究癌症疾病。
    • ¥ 116
    In stock
    规格
    数量
  • FW1256
    T15361117089-08-4
    FW1256 is a phenyl analog. It also a slow-releasing hydrogen sulfide (H2S) donor. FW1256 inhibits NF-κB activity and causes cell apoptosis. FW1256 shows potent anti-inflammatory effects. It also has the potential for cancer and cardiovascular disease trea
    • ¥ 10600
    6-8周
    规格
    数量
  • AP219
    T36240779282-36-9
    AP39 is a compound used to increase the levels of hydrogen sulfide (H2S) within mitochondria. It consists of a mitochondria-targeting motif (triphenylphosphonium) coupled to an H2S-donating moiety (dithiolethione) by an aliphatic linker. AP219 is a control compound for AP39, containing the triphenylphosphonium scaffold but lacking the H2S-releasing portion.
    • 待估
    35日内发货
    规格
    数量
  • ATB-346, (S)-
    T716561000700-29-7
    ATB-346, (S)-, is the S form of ATB-346. ATB-346 is a novel hydrogen sulfide-releasing anti-inflammatory drug which induces apoptosis of human melanoma cells and inhibits melanoma development in vivo.
    • ¥ 10600
    6-8周
    规格
    数量